The distribution of breast cancer subtypes in this study population closely aligns with the proportions reported in a review.9 In this study, Luminal molecular subtypes accounted for 76.2% of the total population, while HER2 enriched made up 8.8% and TNBC comprised 15.0%. This evidence concerns the gene ERBB2 and breast carcinoma.